Epilepsy and the risk of adverse cardiovascular events: A nationwide cohort study.
cardiovascular diseases
comorbidity
epilepsy
incidence
stroke
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
02 Jan 2024
02 Jan 2024
Historique:
revised:
27
09
2023
received:
15
06
2023
accepted:
12
10
2023
medline:
2
1
2024
pubmed:
2
1
2024
entrez:
2
1
2024
Statut:
aheadofprint
Résumé
Epilepsy is associated with higher morbidity and mortality compared to people without epilepsy. We performed a retrospective cross-sectional and longitudinal cohort study to evaluate cardiovascular comorbidity and incident vascular events in people with epilepsy (PWE). Data were extracted from the French Hospital National Database. PWE (n = 682,349) who were hospitalized between January 2014 and December 2022 were matched on age, sex, and year of hospitalization with 682,349 patients without epilepsy. Follow-up was conducted from the date of first hospitalization with epilepsy until the date of each outcome or date of last news in the absence of the outcome. Primary outcome was the incidence of all-cause death, cardiovascular death, myocardial infarction, hospitalization for heart failure, ischaemic stroke (IS), new onset atrial fibrillation, sustained ventricular tachycardia or fibrillation (VT/VF), and cardiac arrest. A diagnosis of epilepsy was associated with higher numbers of cardiovascular risk factors and adverse cardiovascular events compared to controls. People with epilepsy had a higher incidence of all-cause death (incidence rate ratio [IRR] = 2.69, 95% confidence interval [CI] = 2.67-2.72), cardiovascular death (IRR = 2.16, 95% CI = 2.11-2.20), heart failure (IRR = 1.26, 95% CI = 1.25-1.28), IS (IRR = 2.08, 95% CI = 2.04-2.13), VT/VF (IRR = 1.10, 95% CI = 1.04-1.16), and cardiac arrest (IRR = 2.12, 95% CI = 2.04-2.20). When accounting for all-cause death as a competing risk, subdistribution hazard ratios for ischaemic stroke of 1.59 (95% CI = 1.55-1.63) and for cardiac arrest of 1.73 (95% CI = 1.58-1.89) demonstrated higher risk in PWE. The prevalence and incident rates of cardiovascular outcomes were significantly higher in PWE. Targeting cardiovascular health could help reduce excess morbidity and mortality in PWE.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Epilepsy is associated with higher morbidity and mortality compared to people without epilepsy. We performed a retrospective cross-sectional and longitudinal cohort study to evaluate cardiovascular comorbidity and incident vascular events in people with epilepsy (PWE).
METHODS
METHODS
Data were extracted from the French Hospital National Database. PWE (n = 682,349) who were hospitalized between January 2014 and December 2022 were matched on age, sex, and year of hospitalization with 682,349 patients without epilepsy. Follow-up was conducted from the date of first hospitalization with epilepsy until the date of each outcome or date of last news in the absence of the outcome. Primary outcome was the incidence of all-cause death, cardiovascular death, myocardial infarction, hospitalization for heart failure, ischaemic stroke (IS), new onset atrial fibrillation, sustained ventricular tachycardia or fibrillation (VT/VF), and cardiac arrest.
RESULTS
RESULTS
A diagnosis of epilepsy was associated with higher numbers of cardiovascular risk factors and adverse cardiovascular events compared to controls. People with epilepsy had a higher incidence of all-cause death (incidence rate ratio [IRR] = 2.69, 95% confidence interval [CI] = 2.67-2.72), cardiovascular death (IRR = 2.16, 95% CI = 2.11-2.20), heart failure (IRR = 1.26, 95% CI = 1.25-1.28), IS (IRR = 2.08, 95% CI = 2.04-2.13), VT/VF (IRR = 1.10, 95% CI = 1.04-1.16), and cardiac arrest (IRR = 2.12, 95% CI = 2.04-2.20). When accounting for all-cause death as a competing risk, subdistribution hazard ratios for ischaemic stroke of 1.59 (95% CI = 1.55-1.63) and for cardiac arrest of 1.73 (95% CI = 1.58-1.89) demonstrated higher risk in PWE.
CONCLUSIONS
CONCLUSIONS
The prevalence and incident rates of cardiovascular outcomes were significantly higher in PWE. Targeting cardiovascular health could help reduce excess morbidity and mortality in PWE.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy. Neurology. 2017;88(3):296-303. doi:10.1212/WNL.0000000000003509
Lhatoo SD, Johnson AL, Goodridge DM, MacDonald BK, Sander JW, Shorvon SD. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol. 2001;49(3):336-344.
Mbizvo GK, Bennett K, Simpson CR, Duncan SE, Chin RFM. Epilepsy-related and other causes of mortality in people with epilepsy: a systematic review of systematic reviews. Epilepsy Res. 2019;157:106192. doi:10.1016/j.eplepsyres.2019.106192
Verrier RL, Pang TD, Nearing BD, Schachter SC. The epileptic heart: concept and clinical evidence. Epilepsy Behav. 2020;105:106946. doi:10.1016/j.yebeh.2020.106946
Public Health England. Deaths Associated with Neurological Conditions in England 2001 to 2014. 2018. Accessed June 14, 2023. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/683998/Deaths_associated_with_neurological_conditions_data_briefing.pdf
Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34(3):453-458. doi:10.1111/j.1528-1157.1993.tb02586.x
Emsley HCA, Parkes LM. Seizures in the context of occult cerebrovascular disease. Epilepsy Behav. 2020;104:106396. doi:10.1016/j.yebeh.2019.06.039
Hinnell C, Williams J, Metcalfe A, et al. Health status and health-related behaviors in epilepsy compared to other chronic conditions-a national population-based study. Epilepsia. 2010;51(5):853-861. doi:10.1111/j.1528-1167.2009.02477.x
Josephson CB, Wiebe S, Delgado-Garcia G, et al. Association of Enzyme-Inducing Antiseizure Drug use with Long-term Cardiovascular Disease. JAMA Neurol. 2021;78(11):1367. doi:10.1001/jamaneurol.2021.3424
Lai Q, Shen C, Zheng Y, Zhang Y, Guo Y, Ding M. Effects of antiepileptic drugs on the carotid artery intima-media thickness in epileptic patients. J Clin Neurol. 2017;13(4):371-379. doi:10.3988/jcn.2017.13.4.371
Mintzer S, Skidmore CT, Abidin CJ, et al. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol. 2009;65(4):448-456. doi:10.1002/ana.21615
Lee-Lane E, Torabi F, Lacey A, et al. Epilepsy, antiepileptic drugs, and the risk of major cardiovascular events. Epilepsia. 2021;62(7):1604-1616. doi:10.1111/epi.16930
Chantry AA, Deneux-Tharaux C, Cans C, Ego A, Quantin C, Bouvier-Colle MH. Hospital discharge data can be used for monitoring procedures and intensive care related to severe maternal morbidity. J Clin Epidemiol. 2011;64(9):1014-1022. doi:10.1016/j.jclinepi.2010.11.015
Djennaoui M, Ficheur G, Beuscart R, Chazard E. Improvement of the quality of medical databases: data-mining-based prediction of diagnostic codes from previous patient codes. Stud Health Technol Inform. 2015;210:419-423.
Deharo P, Bisson A, Herbert J, et al. Impact of Sapien 3 balloon-expandable versus Evolut R self-expandable Transcatheter aortic valve implantation in patients with aortic stenosis. Circulation. 2020;141(4):260-268. doi:10.1161/CIRCULATIONAHA.119.043971
Lorgis L, Cottenet J, Molins G, et al. Outcomes after acute myocardial infarction in HIV-infected patients. Circulation. 2013;127(17):1767-1774. doi:10.1161/CIRCULATIONAHA.113.001874
Fauchier L, Clementy N, Pelade C, Collignon C, Nicolle E, Lip GYH. Patients with ischemic stroke and incident atrial fibrillation. Stroke. 2015;46(9):2432-2437. doi:10.1161/STROKEAHA.115.010270
Bezin J, Pariente A, Lassalle R, et al. Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol. 2014;70(4):429-436. doi:10.1007/s00228-013-1614-5
Johnson EL, Krauss GL, Lee AK, et al. Association between midlife risk factors and late-onset epilepsy. JAMA Neurol. 2018;75(11):1375-1382. doi:10.1001/jamaneurol.2018.1935
Cvetkovska E, Babunovska M, Boskovski B, Kuzmanovski I, Tanovska N, Trencevska GK. Prevalence of various risk factors associated with new-onset epilepsy after the age of 50: a retrospective population-based study. Epileptic Disord. 2022;24(1):95-101. doi:10.1684/epd.2021.1360
Brigo F, Lochner P, Nardone R, Manganotti P, Lattanzi S. Increased risk of stroke and myocardial infarction in patients with epilepsy: a systematic review of population-based cohort studies. Epilepsy Behav. 2020;104:106307. doi:10.1016/j.yebeh.2019.05.005
Wilson DA, Wannamaker BB, Malek AM, Selassie AW. Myocardial infarction after epilepsy onset: a population-based retrospective cohort study. Epilepsy Behav. 2018;88:181-188. doi:10.1016/j.yebeh.2018.09.009
Chen Z, Liew D, Kwan P. Excess mortality and hospitalised morbidity in newly treated epilepsy patients. Neurology. 2016;87(7):718-725. doi:10.1212/WNL.0000000000002984
Vivanco-Hidalgo RM, Gomez A, Moreira A, Díez L, Elosua R, Roquer J. Prevalence of cardiovascular risk factors in people with epilepsy. Brain Behav. 2017;7(2):e00618. doi:10.1002/brb3.618
Husein N, Josephson CB, Keezer MR. Understanding cardiovascular disease in older adults with epilepsy. Epilepsia. 2021;62(9):2060-2071. doi:10.1111/epi.16991
Doege C, Luedde M, Kostev K. Epilepsy is associated with an increased incidence of heart failure diagnoses. Epilepsy Behav. 2021;125:108393. doi:10.1016/j.yebeh.2021.108393
Johnson AL, McLeish AC, Shear PK, Sheth A, Privitera M. The role of cigarette smoking in epilepsy severity and epilepsy-related quality of life. Epilepsy Behav. 2019;93:38-42. doi:10.1016/j.yebeh.2019.01.041
Terman SW, Aubert CE, Hill CE, Skvarce J, Burke JF, Mintzer S. Cardiovascular disease risk, awareness, and treatment in people with epilepsy. Epilepsy Behav. 2021;117:107878. doi:10.1016/j.yebeh.2021.107878
Hanby MF, Al-Bachari S, Makin F, Vidyasagar R, Parkes LM, Emsley HCA. Structural and physiological MRI correlates of occult cerebrovascular disease in late-onset epilepsy. Neuroimage Clin. 2015;9:128-133. doi:10.1016/j.nicl.2015.07.016
Janszky I, Hallqvist J, Tomson T, Ahlbom A, Mukamal KJ, Ahnve S. Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy-The Stockholm Heart Epidemiology Program. Brain. 2009;132(10):2798-2804. doi:10.1093/brain/awp216
Desai R, Rupareliya C, Patel U, et al. Burden of arrhythmias in epilepsy patients: a Nationwide inpatient analysis of 1.4 million hospitalizations in the United States. Cureus. 2017;9(8):e1550. doi:10.7759/cureus.1550
Kavousi M. Differences in epidemiology and risk factors for atrial fibrillation between women and men. Front Cardiovasc Med. 2020;7:7. doi:10.3389/fcvm.2020.00003
Zaidi A, Clough P, Cooper P, Scheepers B, Fitzpatrick AP. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol. 2000;36(1):181-184. doi:10.1016/S0735-1097(00)00700-2
Williams BA, Chamberlain AM, Blankenship JC, Hylek EM, Voyce S. Trends in atrial fibrillation incidence rates within an integrated health care delivery system, 2006 to 2018. JAMA Netw Open. 2020;3(8):e2014874. doi:10.1001/jamanetworkopen.2020.14874
Doege C, Luedde M, Kostev K. Atrial fibrillation is associated with a subsequent epilepsy diagnosis independent of stroke: a retrospective matched administrative cohort study on 149,632 patients. Epilepsy Behav. 2022;132:108721. doi:10.1016/j.yebeh.2022.108721
Mbizvo GK, Bennett KH, Schnier C, Simpson CR, Duncan SE, Chin RFM. The accuracy of using administrative healthcare data to identify epilepsy cases: a systematic review of validation studies. Epilepsia. 2020;61(7):1319-1335. doi:10.1111/epi.16547
Zaccara G, Lattanzi S. Comorbidity between epilepsy and cardiac arrhythmias: implication for treatment. Epilepsy Behav. 2019;97:304-312. doi:10.1016/j.yebeh.2019.05.038
Buzkova P, Barzilay JI, Mukamal KJ. Assessing risk factors of non-fatal outcomes amid a competing risk of mortality: the example of hip fracture. Osteoporos Int. 2019;30(10):2073-2078. doi:10.1007/s00198-019-05048-w